Literature DB >> 22247002

Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status.

Matthew E Spector1, K Kelly Gallagher, Emily Light, Mohannad Ibrahim, Eric J Chanowski, Jeffrey S Moyer, Mark E Prince, Gregory T Wolf, Carol R Bradford, Kitrina Cordell, Jonathan B McHugh, Thomas Carey, Francis P Worden, Avraham Eisbruch, Douglas B Chepeha.   

Abstract

BACKGROUND: Despite better prognosis, there is a group of oropharyngeal squamous cell carcinoma (SCC) human papillomavirus (HPV)+ patients who experience treatment failure and succumb to distant metastasis.
METHODS: Seventy-eight previously untreated patients nested in a concurrent chemoradiation protocol were reviewed to correlate patterns of local-regional tumor extent to distant metastasis. Biomarker assessment was: HPV in situ hybridization and epidermal growth factor receptor (EGFR) immunointensity.
RESULTS: The 3-year disease-specific survival (DSS) for patients presenting with and without matted nodes was 69% and 94%, respectively (p = .003). Matted nodes were a poor prognostic factor independent of T classification, HPV, EGFR, and smoking status. For patients who were HPV+, 7 of 11 died of distant metastasis and 6 of 7 with distant metastasis had matted nodes.
CONCLUSION: Matted nodes are a novel marker of poor prognosis in oropharyngeal SCC independent of established prognostic factors. Matted nodes may identify patients at risk for the development of distant metastasis who could benefit from systemic therapy, whereas patients without matted nodes may be candidates for de-escalation of therapy.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22247002      PMCID: PMC3424373          DOI: 10.1002/hed.21997

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  15 in total

1.  Changing patterns of failure of head and neck cancer.

Authors:  Charu Taneja; Heidi Allen; R James Koness; Kathy Radie-Keane; Harold J Wanebo
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-03

2.  Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results.

Authors:  Felix Y Feng; Hyungjin M Kim; Teresa H Lyden; Marc J Haxer; Francis P Worden; Mary Feng; Jeffrey S Moyer; Mark E Prince; Thomas E Carey; Gregory T Wolf; Carol R Bradford; Douglas B Chepeha; Avraham Eisbruch
Journal:  J Clin Oncol       Date:  2010-04-26       Impact factor: 44.544

3.  Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.

Authors:  Pernille Lassen; Jesper G Eriksen; Stephen Hamilton-Dutoit; Trine Tramm; Jan Alsner; Jens Overgaard
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

4.  Accuracy of CT in detecting squamous carcinoma metastases in cervical lymph nodes.

Authors:  P Carvalho; D Baldwin; R Carter; C Parsons
Journal:  Clin Radiol       Date:  1991-08       Impact factor: 2.350

5.  Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.

Authors:  Jason T Rich; Simon Milov; James S Lewis; Wade L Thorstad; Douglas R Adkins; Bruce H Haughey
Journal:  Laryngoscope       Date:  2009-09       Impact factor: 3.325

6.  HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer.

Authors:  Jan Klozar; Vit Kratochvil; Martina Salakova; Jana Smahelova; Eva Vesela; Eva Hamsikova; Jan Betka; Ruth Tachezy
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-12-20       Impact factor: 2.503

7.  EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.

Authors:  Bhavna Kumar; Kitrina G Cordell; Julia S Lee; Francis P Worden; Mark E Prince; Huong H Tran; Gregory T Wolf; Susan G Urba; Douglas B Chepeha; Theodoros N Teknos; Avraham Eisbruch; Christina I Tsien; Jeremy M G Taylor; Nisha J D'Silva; Kun Yang; David M Kurnit; Joshua A Bauer; Carol R Bradford; Thomas E Carey
Journal:  J Clin Oncol       Date:  2008-05-12       Impact factor: 44.544

8.  Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.

Authors:  Marshall R Posner; Diane M Hershock; Cesar R Blajman; Elizabeth Mickiewicz; Eric Winquist; Vera Gorbounova; Sergei Tjulandin; Dong M Shin; Kevin Cullen; Thomas J Ervin; Barbara A Murphy; Luis E Raez; Roger B Cohen; Monica Spaulding; Roy B Tishler; Berta Roth; Rosana del Carmen Viroglio; Varagur Venkatesan; Ilya Romanov; Sanjiv Agarwala; K William Harter; Matthew Dugan; Anthony Cmelak; Arnold M Markoe; Paul W Read; Lynn Steinbrenner; A Dimitrios Colevas; Charles M Norris; Robert I Haddad
Journal:  N Engl J Med       Date:  2007-10-25       Impact factor: 91.245

9.  Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.

Authors:  Felix Y Feng; Hyungjin M Kim; Teresa H Lyden; Marc J Haxer; Mary Feng; Frank P Worden; Douglas B Chepeha; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-06-07       Impact factor: 7.038

10.  Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure.

Authors:  Megan E Daly; Quynh-Thu Le; Peter G Maxim; Billy W Loo; Michael J Kaplan; Nancy J Fischbein; Harlan Pinto; Daniel T Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-18       Impact factor: 7.038

View more
  26 in total

1.  Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Matthew E Spector; Jonathan B McHugh; Ka Kit Wong; Heather M Walline; Serena A Byrd; Christine M Komarck; Mohannad Ibrahim; Matthew H Stenmark; Mark E Prince; Carol R Bradford; Gregory T Wolf; Scott McLean; Francis P Worden; Douglas B Chepeha; Thomas Carey; Avraham Eisbruch
Journal:  Oral Oncol       Date:  2014-02-22       Impact factor: 5.337

Review 2.  Prognostic biological features in neck dissection specimens.

Authors:  Julia A Woolgar; Asterios Triantafyllou; James S Lewis; Jennifer Hunt; Michelle D Williams; Robert P Takes; Lester D R Thompson; Pieter J Slootweg; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-15       Impact factor: 2.503

3.  Matted nodes as a predictor of distant metastasis in advanced-stage III/IV oropharyngeal squamous cell carcinoma.

Authors:  Matthew E Spector; Steven B Chinn; Emily Bellile; K Kelly Gallagher; Mohannad Ibrahim; Jeffrey Vainshtein; Eric J Chanowski; Heather M Walline; Jeffrey S Moyer; Mark E Prince; Gregory T Wolf; Carol R Bradford; Jonathan B McHugh; Thomas Carey; Francis P Worden; Avraham Eisbruch; Douglas B Chepeha
Journal:  Head Neck       Date:  2015-06-30       Impact factor: 3.147

4.  Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma.

Authors:  Volkert B Wreesmann; Nora Katabi; Frank L Palmer; Pablo H Montero; Jocelyn C Migliacci; Mithat Gönen; Diane Carlson; Ian Ganly; Jatin P Shah; Ronald Ghossein; Snehal G Patel
Journal:  Head Neck       Date:  2015-10-30       Impact factor: 3.147

5.  Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.

Authors:  Takatsugu Mizumachi; Akihiro Homma; Tomohiro Sakashita; Satoshi Kano; Hiromitsu Hatakeyama; Satoshi Fukuda
Journal:  Int J Clin Oncol       Date:  2017-03-07       Impact factor: 3.402

6.  E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.

Authors:  Matthew E Spector; Assuntina G Sacco; Emily Bellile; Jeremy M G Taylor; Tamara Jones; Kan Sun; William C Brown; Andrew C Birkeland; Carol R Bradford; Gregory T Wolf; Mark E Prince; Jeffrey S Moyer; Kelly Malloy; Paul Swiecicki; Avraham Eisbruch; Jonathan B McHugh; Douglas B Chepeha; Laura Rozek; Francis P Worden
Journal:  Clin Cancer Res       Date:  2016-11-21       Impact factor: 12.531

7.  Matted nodes: High distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer.

Authors:  Jeffrey M Vainshtein; Matthew E Spector; Mohannad Ibrahim; Carol R Bradford; Gregory T Wolf; Matthew H Stenmark; Francis P Worden; Jonathan B McHugh; Mark E Prince; Thomas Carey; Douglas B Chepeha; Avraham Eisbruch
Journal:  Head Neck       Date:  2015-07-15       Impact factor: 3.147

8.  Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.

Authors:  Takatsugu Mizumachi; Akihiro Homma; Tomohiko Kakizaki; Tomohiro Sakashita; Satoshi Kano; Hiromitsu Hatakeyama; Kazuhiko Tsuchiya; Koichi Yasuda; Rikiya Onimaru; Hiroki Shirato; Jun Taguchi; Yasushi Shimizu; Ichiro Kinoshita; Hirotoshi Akita; Satoshi Fukuda
Journal:  Int J Clin Oncol       Date:  2014-07-05       Impact factor: 3.402

9.  Human papillomavirus-related oropharyngeal cancer: HPV and p16 status in the recurrent versus parent tumor.

Authors:  Jeffrey Vainshtein; Jonathan B McHugh; Matthew E Spector; Heather M Walline; Christine M Komarck; Matthew H Stenmark; Mark E Prince; Francis P Worden; Gregory T Wolf; Carol R Bradford; Douglas B Chepeha; Thomas Carey; Avraham Eisbruch
Journal:  Head Neck       Date:  2014-04-15       Impact factor: 3.147

10.  Highly aggressive human papillomavirus-related oropharyngeal cancer: clinical, radiologic, and pathologic characteristics.

Authors:  Azeem S Kaka; Bhavna Kumar; Pawan Kumar; Paul E Wakely; Claudia M Kirsch; Matthew O Old; Enver Ozer; Amit Agrawal; Ricardo E Carrau; David E Schuller; Farzan Siddiqui; Theodoros N Teknos
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2013-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.